We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Latest Articles

Proteomics, "Zombie" Cells and Clinical Biomarkers of Aging
Article

In a new study scientists have harnessed advances in proteomics to extensively profile the secretions of senescent cells which are implicated in aging. Their analyses are collated in a database that is now available for researchers in the field.

READ MORE

Exploring the Medicinal Benefits of Cannabis Within UK Pharmaceuticals
Article

In this article, we explore how the use of cannabis within UK pharmaceuticals is expected to change, as well as the medicinal benefits offered by cannabis, and cannabinoids.

READ MORE

The Importance of Understanding Target–Protein Interactions in Drug Discovery
Article

You’re unwell, you see a doctor, they prescribe you a medicine… and you take it. But how exactly is that drug having an effect? What is its mechanism of action? Drugs exhibit their effects through specific protein–target interactions. Andrew Lynn, Chief Executive Officer at Fluidic Analytics discusses why understanding protein–target interactions is so important.

READ MORE

Incidence vs Prevalence
Article

In epidemiology, prevalence and incidence are among the most fundamental measures when it comes to monitoring disease. But do you know what they mean or how and why they are important? This article takes a look at disease prevalence and incidence, what this information tells us and how it can be used.

READ MORE

Complementary Bonds: Strategic Collaboration Between ELRIG and BPS Announced at Pharmacology 2019
Article

A new collaboration was announced Monday between the British Pharmacological Society (BPS) and scientific not-for-profit The European Laboratory Research & Innovation Group (ELRIG) UK at the annual Pharmacology 2019 meeting in Edinburgh, Scotland.

READ MORE

Advances in High-throughput Screening
Article

Ever since the advent of the multi-well plate, researchers have been pioneering new ways to miniaturize assays for high-throughput screening (HTS). Here, we share two examples that illustrate the power of modern HTS in drug discovery.

READ MORE

The Pursuit of Spotting and Steering Cell Death
Article

Here, we examine one common branch of cell death, apoptosis, and explain why studying aberrations in apoptotic signaling is important for understanding and addressing a range of human pathologies. We also highlight techniques that enable studies of apoptosis.

READ MORE

The Power of Collaboration: Tackling Pharmaceutical Challenges
Article

In this article, we explore how pharmaceutical companies have started to embrace a more collaborative way of working as part of a movement to help overcome some of the challenges the industry is facing.

READ MORE

Brexit – Liberation or Limitation for the Life Sciences Sector?
Article

We’re now somewhere between the second and third attempt at the UK leaving the EU. Yet, as we approach the turn of the year, the future remains opaque. What impact will Brexit have on the life sciences sector?

READ MORE

Scientists Left Perplexed at Latest Alzheimer’s Drug Data
Article

In this article, we revisit the many twists and turns of the aducanumab clinical trials and explore the scientific community's response to the latest analysis of the data.

READ MORE